{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:19:09Z","timestamp":1793117949939,"version":"4.5.0"},"reference-count":185,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Cognitive impairment associated with schizophrenia (CIAS) represents one of the core features of the disorder and has a significant impact on functional and rehabilitation outcomes of people living with schizophrenia spectrum disorders (SSD). The aim of this critical review is to highlight the most recent evidence on effective treatments available for CIAS, to discuss the current challenges in this field, and to present future perspectives that may help to overcome them. Concerning psychopharmacological approaches, among the most indicated strategies for the management and prevention of CIAS is to favor second-generation antipsychotic medications and avoid long-term and high-dose treatments with anticholinergic medications and benzodiazepines. Moreover, non-pharmacological approaches such as cognitive remediation and physical exercise-based programs represent evidence-based interventions in the treatment of CIAS that have shown reliable evidence of effectiveness on both cognitive and functional outcomes. These treatments, however, are still delivered to people accessing mental health services with a diagnosis of CIAS in an uneven manner, even in high-income countries. Academic and clinical partnership and collaboration, as well as advocacy from service users, families, carers, and stakeholders\u2019 organizations could help to reduce the bench to bedside gap in the treatment of CIAS. Future perspectives include the development of novel pharmacological agents that could be effective in the treatment of CIAS, the implementation of novel technologies such as telemedicine and virtual reality in the delivery of evidence-based interventions to improve accessibility and engagement, and further research in the field of non-invasive brain stimulation.<\/jats:p>","DOI":"10.3390\/brainsci14080791","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T11:54:19Z","timestamp":1722945259000},"page":"791","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Treatment of Cognitive Impairment Associated with Schizophrenia Spectrum Disorders: New Evidence, Challenges, and Future Perspectives"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3098-4668","authenticated-orcid":false,"given":"Irene","family":"Calzavara-Pinton","sequence":"first","affiliation":[{"name":"Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Nibbio","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1784-3915","authenticated-orcid":false,"given":"Stefano","family":"Barlati","sequence":"additional","affiliation":[{"name":"Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, 25123 Brescia, Italy"},{"name":"Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Bertoni","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Necchini","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Zardini","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Baglioni","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Paolini","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Poddighe","sequence":"additional","affiliation":[{"name":"Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Bulgari","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4091-6502","authenticated-orcid":false,"given":"Jacopo","family":"Lisoni","sequence":"additional","affiliation":[{"name":"Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Deste","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy"},{"name":"Department of Mental Health, ASST Valcamonica, 25040 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vita","sequence":"additional","affiliation":[{"name":"Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, 25123 Brescia, Italy"},{"name":"Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/wps.20167","article-title":"The Influence of Illness-Related Variables, Personal Resources and Context-Related Factors on Real-Life Functioning of People with Schizophrenia","volume":"13","author":"Galderisi","year":"2014","journal-title":"World Psychiatry"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1093\/schbul\/sbu006","article-title":"Schizophrenia--Time to Commit to Policy Change","volume":"40","author":"Fleischhacker","year":"2014","journal-title":"Schizophr. Bull."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2023.11.015","article-title":"The Schizophrenia Syndrome, circa 2024: What We Know and How That Informs Its Nature","volume":"264","author":"Tandon","year":"2023","journal-title":"Schizophr. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/wps.20809","article-title":"The Clinical Characterization of the Patient with Primary Psychosis Aimed at Personalization of Management","volume":"20","author":"Maj","year":"2021","journal-title":"World Psychiatry"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s41380-023-02388-2","article-title":"Psychosis Superspectrum I: Nosology, Etiology, and Lifespan Development","volume":"29","author":"Jonas","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1192\/j.eurpsy.2020.99","article-title":"The Influence of Autistic Symptoms on Social and Non-Social Cognition and on Real-Life Functioning in People with Schizophrenia: Evidence from the Italian Network for Research on Psychoses Multicenter Study","volume":"63","author":"Vita","year":"2020","journal-title":"Eur. Psychiatry"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.schres.2021.06.007","article-title":"Internalized Stigma among People with Schizophrenia: Relationship with Socio-Demographic, Clinical and Medication-Related Features","volume":"243","author":"Barlati","year":"2022","journal-title":"Schizophr. Res."},{"key":"ref_8","first-page":"1411","article-title":"Self-Perceived Cognitive Deficits and Their Relationship with Internalized Stigma and Quality of Life in Patients with Schizophrenia","volume":"12","author":"Shin","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"112950","DOI":"10.1016\/j.psychres.2020.112950","article-title":"The Impact of Illness Identity on Recovery from Severe Mental Illness: A Review of the Evidence","volume":"288","author":"Yanos","year":"2020","journal-title":"Psychiatry Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","article-title":"Cognitive Impairment in Schizophrenia: Aetiology, Pathophysiology, and Treatment","volume":"28","author":"McCutcheon","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"100249","DOI":"10.1016\/j.scog.2022.100249","article-title":"Cognitive Dysfunction in Schizophrenia: An Expert Group Paper on the Current State of the Art","volume":"29","author":"Harvey","year":"2022","journal-title":"Schizophr. Res. Cogn."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/wps.20624","article-title":"Nonsocial and Social Cognition in Schizophrenia: Current Evidence and Future Directions","volume":"18","author":"Green","year":"2019","journal-title":"World Psychiatry"},{"key":"ref_13","first-page":"436","article-title":"Die Prognose Der Dementia Praecox (Schizophreniegruppe)","volume":"65","author":"Bleuler","year":"1908","journal-title":"Allg. Z. Psychiat"},{"key":"ref_14","unstructured":"Kraepelin, E., and Barclay, R. (1919). Dementia Praecox. Cut. Shepherd, 13\u201324."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.31887\/DCNS.2019.21.3\/amccleery","article-title":"Cognitive Impairment in Psychotic Illness: Prevalence, Profile of Impairment, Developmental Course, and Treatment Considerations","volume":"21","author":"McCleery","year":"2019","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.schres.2013.07.009","article-title":"The Global Cognitive Impairment in Schizophrenia: Consistent over Decades and around the World","volume":"150","author":"Schaefer","year":"2013","journal-title":"Schizophr. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1192\/j.eurpsy.2022.2316","article-title":"European Psychiatric Association Guidance on Assessment of Cognitive Impairment in Schizophrenia","volume":"65","author":"Vita","year":"2022","journal-title":"Eur. Psychiatry"},{"key":"ref_18","first-page":"562","article-title":"Cognitive Functioning in Prodromal Psychosis: A Meta-Analysis","volume":"69","author":"Deste","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Aas, M., Dazzan, P., Mondelli, V., Melle, I., Murray, R.M., and Pariante, C.M. (2014). A Systematic Review of Cognitive Function in First-Episode Psychosis, Including a Discussion on Childhood Trauma, Stress, and Inflammation. Front. Psychiatry, 4.","DOI":"10.3389\/fpsyt.2013.00182"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.schres.2014.04.039","article-title":"Cognitive Functioning in First-Episode Schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment","volume":"157","author":"McCleery","year":"2014","journal-title":"Schizophr. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1017\/S0033291717001970","article-title":"Cognitive Development Prior to Onset of Psychosis","volume":"48","author":"Mollon","year":"2018","journal-title":"Psychol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1176\/appi.ajp.2007.07010042","article-title":"The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity","volume":"165","author":"Nuechterlein","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.31887\/DCNS.2010.12.3\/areichenberg","article-title":"The Assessment of Neuropsychological Functioning in Schizophrenia","volume":"12","author":"Reichenberg","year":"2010","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/schbul\/sbl029","article-title":"The Functional Significance of Social Cognition in Schizophrenia: A Review","volume":"32","author":"Couture","year":"2006","journal-title":"Schizophr. Bull."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/schbul\/sbx117","article-title":"Social Cognition Psychometric Evaluation: Results of the Final Validation Study","volume":"44","author":"Pinkham","year":"2018","journal-title":"Schizophr. Bull."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Barlati, S., Minelli, A., Ceraso, A., Nibbio, G., Carvalho Silva, R., Deste, G., Turrina, C., and Vita, A. (2020). Social Cognition in a Research Domain Criteria Perspective: A Bridge between Schizophrenia and Autism Spectra Disorders. Front. Psychiatry, 11.","DOI":"10.3389\/fpsyt.2020.00806"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1001\/jamapsychiatry.2017.4607","article-title":"Interplay Among Psychopathologic Variables, Personal Resources, Context-Related Factors, and Real-Life Functioning in Individuals with Schizophrenia: A Network Analysis","volume":"75","author":"Galderisi","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.wpsyc.2012.05.004","article-title":"Predicting the Severity of Everyday Functional Disability in People with Schizophrenia: Cognitive Deficits, Functional Capacity, Symptoms, and Health Status","volume":"11","author":"Harvey","year":"2012","journal-title":"World Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Deste, G., Vita, A., Nibbio, G., Penn, D.L., Pinkham, A.E., and Harvey, P.D. (2020). Autistic Symptoms and Social Cognition Predict Real-World Outcomes in Patients with Schizophrenia. Front. Psychiatry, 11.","DOI":"10.3389\/fpsyt.2020.00524"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/schbul\/sbq077","article-title":"Neurocognitive Predictors of Objective and Subjective Quality of Life in Individuals with Schizophrenia: A Meta-Analytic Investigation","volume":"38","author":"Tolman","year":"2012","journal-title":"Schizophr. Bull."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.psychres.2018.07.003","article-title":"Quality of Life in Chinese Patients with Schizophrenia: A Meta-Analysis","volume":"268","author":"Lu","year":"2018","journal-title":"Psychiatry Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1017\/S0033291720003311","article-title":"The Puzzle of Quality of Life in Schizophrenia: Putting the Pieces Together with the FACE-SZ Cohort","volume":"52","author":"Ehrminger","year":"2022","journal-title":"Psychol. Med."},{"key":"ref_33","first-page":"42345","article-title":"Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia","volume":"83","author":"Correll","year":"2022","journal-title":"J. Clin. Psychiatry"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"7943","DOI":"10.1017\/S0033291723002106","article-title":"Life Engagement in People Living with Schizophrenia: Predictors and Correlates of Patient Life Engagement in a Large Sample of People Living in the Community","volume":"53","author":"Vita","year":"2023","journal-title":"Psychol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1093\/schbul\/sbv163","article-title":"Treatment of Cognition in the Schizophrenia Spectrum: The Context of Psychiatric Rehabilitation","volume":"42","author":"Spaulding","year":"2016","journal-title":"Schizophr. Bull."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/YCO.0000000000000407","article-title":"Recovery from Schizophrenia: Is It Possible?","volume":"31","author":"Vita","year":"2018","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/pcn.13342","article-title":"Toward Recovery in Schizophrenia: Current Concepts, Findings, and Future Research Directions","volume":"76","author":"Onitsuka","year":"2022","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00406-022-01510-9","article-title":"Cognitive and Clinical Characteristics of Offenders and Non-Offenders Diagnosed with Schizophrenia Spectrum Disorders: Results of the Recoviwel Observational Study","volume":"273","author":"Barlati","year":"2023","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.scog.2014.06.001","article-title":"Cognitive Predictors of Violence in Schizophrenia: A Meta-Analytic Review","volume":"1","author":"Reinharth","year":"2014","journal-title":"Schizophr. Res. Cogn."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41398-021-01749-1","article-title":"Neurocognition and Social Cognition in Patients with Schizophrenia Spectrum Disorders with and without a History of Violence: Results of a Multinational European Study","volume":"11","author":"Iozzino","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/00938548231225260","article-title":"Executive Functioning and Offending Behavior: An Updated Meta-Analysis","volume":"51","author":"Griffith","year":"2024","journal-title":"Crim. Justice Behav."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S2215-0366(17)30165-7","article-title":"Ethnicity, Mortality, and Severe Mental Illness","volume":"4","author":"Giannouli","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.schres.2021.01.013","article-title":"Where Do We Cut the Bell-Shaped Curve of CIAS?","volume":"228","author":"Keefe","year":"2021","journal-title":"Schizophr. Res."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Barch, D.M., and Young, J.W. (2023). An Update on Treatment of Cognitive Impairment Associated with Schizophrenia. Cognitive Functioning in Schizophrenia: Leveraging the RDoC Framework, Springer International Publishing. Current Topics in Behavioral Neurosciences.","DOI":"10.1007\/978-3-031-26441-2"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"sgae013","DOI":"10.1093\/schizbullopen\/sgae013","article-title":"Pharmacological Treatment of Cognitive Impairment Associated with Schizophrenia: State of the Art and Future Perspectives","volume":"5","author":"Vita","year":"2024","journal-title":"Schizophr. Bull. Open"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0269881119889296","article-title":"Evidence-Based Guidelines for the Pharmacological Treatment of Schizophrenia: Updated Recommendations from the British Association for Psychopharmacology","volume":"34","author":"Barnes","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0004867416641195","article-title":"Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines for the Management of Schizophrenia and Related Disorders","volume":"50","author":"Galletly","year":"2016","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1176\/appi.ajp.2020.177901","article-title":"The American Psychiatric Association Practice Guideline for the Treatment of Patients with Schizophrenia","volume":"177","author":"Keepers","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/0706743717720448","article-title":"Guidelines for the Pharmacotherapy of Schizophrenia in Adults","volume":"62","author":"Remington","year":"2017","journal-title":"Can. J. Psychiatry"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1192\/j.eurpsy.2022.2315","article-title":"European Psychiatric Association Guidance on Treatment of Cognitive Impairment in Schizophrenia","volume":"65","author":"Vita","year":"2022","journal-title":"Eur. Psychiatry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2147\/TCRM.S117321","article-title":"Safety, Tolerability, and Risks Associated with First- and Second-Generation Antipsychotics: A State-of-the-Art Clinical Review","volume":"13","author":"Solmi","year":"2017","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S2215-0366(19)30302-5","article-title":"Glial Cells in Schizophrenia: A Unified Hypothesis","volume":"7","author":"Dietz","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"ref_53","first-page":"e23959","article-title":"Neurobiology of Schizophrenia: A Comprehensive Review","volume":"14","author":"Luvsannyam","year":"2022","journal-title":"Cureus"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamapsychiatry.2019.3360","article-title":"Schizophrenia-An Overview","volume":"77","author":"McCutcheon","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/jamapsychiatry.2021.0620","article-title":"Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials","volume":"78","author":"Vita","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Vita, A., and Barlati, S. (2019). The Implementation of Evidence-Based Psychiatric Rehabilitation: Challenges and Opportunities for Mental Health Services. Front. Psychiatry, 10.","DOI":"10.3389\/fpsyt.2019.00147"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/schbul\/sbv018","article-title":"The \u201cRight Stuff\u201d Revisited: What Have We Learned About the Determinants of Daily Functioning in Schizophrenia?","volume":"41","author":"Green","year":"2015","journal-title":"Schizophr. Bull."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Wykes, T., Bowie, C.R., and Cella, M. (2024). Thinking About the Future of Cognitive Remediation Therapy Revisited: What Is Left to Solve Before Patients Have Access?. Schizophr. Bull., sbae075.","DOI":"10.1093\/schbul\/sbae075"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/YCO.0000000000000925","article-title":"Evidence-Based Psychosocial Interventions in Schizophrenia: A Critical Review","volume":"37","author":"Barlati","year":"2024","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1017\/S1121189X00002918","article-title":"Comparison of Systematic and Narrative Reviews: The Example of the Atypical Antipsychotics","volume":"12","author":"Cipriani","year":"2003","journal-title":"Epidemiol. Psichiatr. Soc."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1179\/2047480615Z.000000000329","article-title":"Writing Narrative Style Literature Reviews","volume":"24","author":"Ferrari","year":"2015","journal-title":"Med. Writ."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neubiorev.2021.03.028","article-title":"The Effect of Antipsychotics on the Cognitive Performance of Individuals with Psychotic Disorders: Network Meta-Analyses of Randomized Controlled Trials","volume":"126","author":"Baldez","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00228-013-1600-y","article-title":"Long-Term Neurocognitive Effects of Antipsychotics in Schizophrenia: A Network Meta-Analysis","volume":"70","author":"Schurhoff","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/acps.12374","article-title":"Second-Generation Antipsychotic Effect on Cognition in Patients with Schizophrenia\u2014A Meta-Analysis of Randomized Clinical Trials","volume":"131","author":"Nielsen","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/13803395.2018.1488952","article-title":"Comparing the Effect of the Subcategories of Atypical Antipsychotic Medications on Cognition in Schizophrenia Using a Meta-Analytic Approach","volume":"41","author":"Clissold","year":"2019","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/JCP.0000000000001232","article-title":"Safety and Efficacy in Randomized Controlled Trials of Second-Generation Antipsychotics Versus Placebo for Cognitive Impairments in Schizophrenia: A Meta-Analysis","volume":"42","author":"Ohi","year":"2022","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.euroneuro.2019.06.008","article-title":"Novel Antipsychotics Specificity Profile: A Clinically Oriented Review of Lurasidone, Brexpiprazole, Cariprazine and Lumateperone","volume":"29","author":"Corponi","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eurpsy.2019.01.015","article-title":"The Efficacy of Cariprazine in Negative Symptoms of Schizophrenia: Post Hoc Analyses of PANSS Individual Items and PANSS-Derived Factors","volume":"58","author":"Fleischhacker","year":"2019","journal-title":"Eur. Psychiatry"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.2174\/1570159X21666230727140843","article-title":"Cognitive Effects of Lurasidone and Cariprazine: A Mini Systematic Review","volume":"21","author":"Olivola","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/TCRM.S94060","article-title":"Clinical Role of Brexpiprazole in Depression and Schizophrenia","volume":"13","author":"Parikh","year":"2017","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/JCP.0000000000000790","article-title":"The Impact of Medication Anticholinergic Burden on Cognitive Performance in People with Schizophrenia","volume":"37","author":"Ang","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/s41386-021-01057-8","article-title":"Genome-Wide Association Study Accounting for Anticholinergic Burden to Examine Cognitive Dysfunction in Psychotic Disorders","volume":"46","author":"Eum","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.schres.2017.03.034","article-title":"Cognitive Burden of Anticholinergic Medications in Psychotic Disorders","volume":"190","author":"Eum","year":"2017","journal-title":"Schizophr. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/schbul\/sbaa093","article-title":"The Impact of Anticholinergic Burden on Functional Capacity in Persons with Schizophrenia Across the Adult Life Span","volume":"47","author":"Khan","year":"2021","journal-title":"Schizophr. Bull."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1176\/appi.ajp.2020.20081212","article-title":"Anticholinergic Medication Burden\u2013Associated Cognitive Impairment in Schizophrenia","volume":"178","author":"Joshi","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Barch, D.M., and Young, J.W. (2023). Cholinergic Functioning, Cognition, and Anticholinergic Medication Burden in Schizophrenia. Cognitive Functioning in Schizophrenia: Leveraging the RDoC Framework, Springer International Publishing. Current Topics in Behavioral Neurosciences.","DOI":"10.1007\/978-3-031-26441-2"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.schres.2023.08.015","article-title":"Effect of Anticholinergic Burden on Brain Activity during Working Memory and Real-World Functioning in Patients with Schizophrenia","volume":"260","author":"Selvaggi","year":"2023","journal-title":"Schizophr. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1017\/S0033291716002154","article-title":"Anticholinergic Burden in Schizophrenia and Ability to Benefit from Psychosocial Treatment Programmes: A 3-Year Prospective Cohort Study","volume":"46","author":"Donohoe","year":"2016","journal-title":"Psychol. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1176\/appi.ajp.2009.09010017","article-title":"The Cognitive Cost of Anticholinergic Burden: Decreased Response to Cognitive Training in Schizophrenia","volume":"166","author":"Vinogradov","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00406-017-0787-9","article-title":"Benzodiazepine Long-Term Administration Is Associated with Impaired Attention\/Working Memory in Schizophrenia: Results from the National Multicentre FACE-SZ Data Set","volume":"268","author":"Fond","year":"2018","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1017\/S1041610219000358","article-title":"Benzodiazepine Use among Older Adults with Schizophrenia Spectrum Disorder: Prevalence and Associated Factors in a Multicenter Study","volume":"32","author":"Schuster","year":"2020","journal-title":"Int. Psychogeriatr."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s40263-022-00935-z","article-title":"Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia","volume":"36","author":"Neuner","year":"2022","journal-title":"CNS Drugs"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/JCP.0000000000001115","article-title":"Adjunctive Memantine Treatment of Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Study","volume":"39","author":"Hassanpour","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_84","first-page":"258","article-title":"The Effect of Memantine Versus Folic Acid on Cognitive Impairment in Patients with Schizophrenia: A Randomized Clinical Trial","volume":"18","author":"Hosseini","year":"2023","journal-title":"Iran. J. Psychiatry"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/a-0970-9310","article-title":"Acute and Long-Term Memantine Add-on Treatment to Risperidone Improves Cognitive Dysfunction in Patients with Acute and Chronic Schizophrenia","volume":"53","author":"Schaefer","year":"2020","journal-title":"Pharmacopsychiatry"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"113285","DOI":"10.1016\/j.psychres.2020.113285","article-title":"Meta-Analysis of Randomized Controlled Trials of Galantamine in Schizophrenia: Significant Cognitive Enhancement","volume":"291","author":"Koola","year":"2020","journal-title":"Psychiatry Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"10","DOI":"10.9758\/cpn.2020.18.1.10","article-title":"Anti-Inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing","volume":"18","author":"Hong","year":"2020","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"ref_88","unstructured":"Khandaker, G.M., Meyer, U., and Jones, P.B. (2020). Inflammation, Antipsychotic Drugs, and Evidence for Effectiveness of Anti-Inflammatory Agents in Schizophrenia. Neuroinflammation and Schizophrenia, Springer International Publishing. Current Topics in Behavioral Neurosciences."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/schbul\/sbt139","article-title":"Efficacy of Anti-Inflammatory Agents to Improve Symptoms in Patients with Schizophrenia: An Update","volume":"40","author":"Sommer","year":"2014","journal-title":"Schizophr. Bull."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1177\/0004867419835028","article-title":"Adjunctive Use of Anti-Inflammatory Drugs for Schizophrenia: A Meta-Analytic Investigation of Randomized Controlled Trials","volume":"53","author":"Cho","year":"2019","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/0004867419893439","article-title":"Meta-Analysis of Randomised Controlled Trials with N-Acetylcysteine in the Treatment of Schizophrenia","volume":"54","author":"Yolland","year":"2020","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1017\/S0033291719001995","article-title":"An Update on the Efficacy of Anti-Inflammatory Agents for Patients with Schizophrenia: A Meta-Analysis","volume":"49","author":"Koola","year":"2019","journal-title":"Psychol. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.schres.2019.08.005","article-title":"The Effect of Minocycline on Amelioration of Cognitive Deficits and Pro-Inflammatory Cytokines Levels in Patients with Schizophrenia","volume":"212","author":"Zhang","year":"2019","journal-title":"Schizophr. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s13318-017-0440-z","article-title":"Safety, Tolerability and Pharmacokinetics of Oral BI 425809, a Glycine Transporter 1 Inhibitor, in Healthy Male Volunteers: A Partially Randomised, Single-Blind, Placebo-Controlled, First-in-Human Study","volume":"43","author":"Moschetti","year":"2018","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s40261-018-0660-2","article-title":"Multiple Rising Doses of Oral BI 425809, a GlyT1 Inhibitor, in Young and Elderly Healthy Volunteers: A Randomised, Double-Blind, Phase I Study Investigating Safety and Pharmacokinetics","volume":"38","author":"Moschetti","year":"2018","journal-title":"Clin. Drug Investig."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.clinthera.2019.03.014","article-title":"Pharmacokinetics of Single Doses of BI 425809 in Healthy Chinese and Japanese Subjects: A Randomized Study","volume":"41","author":"Tsuda","year":"2019","journal-title":"Clin. Ther."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S2215-0366(20)30513-7","article-title":"Efficacy and Safety of the Novel Glycine Transporter Inhibitor BI 425809 Once Daily in Patients with Schizophrenia: A Double-Blind, Randomised, Placebo-Controlled Phase 2 Study","volume":"8","author":"Fleischhacker","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1007\/s11064-023-03956-2","article-title":"Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia","volume":"48","author":"Fradley","year":"2023","journal-title":"Neurochem. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41386-023-01560-0","article-title":"The D-Amino Acid Oxidase Inhibitor Luvadaxistat Improves Mismatch Negativity in Patients with Schizophrenia in a Randomized Trial","volume":"48","author":"Dong","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.schres.2024.06.017","article-title":"INTERACT: A Randomized Phase 2 Study of the DAAO Inhibitor Luvadaxistat in Adults with Schizophrenia","volume":"270","author":"Murthy","year":"2024","journal-title":"Schizophr. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41398-022-02254-9","article-title":"Effectiveness of KarXT (Xanomeline-Trospium) for Cognitive Impairment in Schizophrenia: Post Hoc Analyses from a Randomised, Double-Blind, Placebo-Controlled Phase 2 Study","volume":"12","author":"Sauder","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0140-6736(23)02190-6","article-title":"Efficacy and Safety of the Muscarinic Receptor Agonist KarXT (Xanomeline\u2013Trospium) in Schizophrenia (EMERGENT-2) in the USA: Results from a Randomised, Double-Blind, Placebo-Controlled, Flexible-Dose Phase 3 Trial","volume":"403","author":"Kaul","year":"2024","journal-title":"Lancet"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00213-023-06362-2","article-title":"Evidence of Trospium\u2019s Ability to Mitigate Cholinergic Adverse Events Related to Xanomeline: Phase 1 Study Results","volume":"240","author":"Breier","year":"2023","journal-title":"Psychopharmacology"},{"key":"ref_104","unstructured":"Nibbio, G., Pinton, I.C., Bertoni, L., Cicale, A., Necchini, N., Zardini, D., Poddighe, L., Lisoni, J., Deste, G., and Barlati, S. (2024). Non-Pharmacological Interventions to Improve Cognitive Impairment and Psychosocial Functioning in Schizophrenia: A Critical Review. J. Psychopathol., 30."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41380-022-01727-z","article-title":"Efficacy and Acceptability of Psychosocial Interventions in Schizophrenia: Systematic Overview and Quality Appraisal of the Meta-Analytic Evidence","volume":"28","author":"Solmi","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Fitapelli, B., and Lindenmayer, J.-P. (2022). Advances in Cognitive Remediation Training in Schizophrenia: A Review. Brain Sci., 12.","DOI":"10.3390\/brainsci12020129"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/bjc.12320","article-title":"A Meta-Analysis of the Effects of Social-Cognitive Training in Schizophrenia: The Role of Treatment Characteristics and Study Quality","volume":"61","author":"Yeo","year":"2022","journal-title":"Br. J. Clin. Psychol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/schbul\/sbab022","article-title":"A Meta-Analysis of Cognitive Remediation for Schizophrenia: Efficacy and the Role of Participant and Treatment Factors","volume":"47","author":"Lejeune","year":"2021","journal-title":"Schizophr. Bull."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.neubiorev.2019.09.031","article-title":"Multi-Outcome Meta-Analysis (MOMA) of Cognitive Remediation in Schizophrenia: Revisiting the Relevance of Human Coaching and Elucidating Interplay between Multiple Outcomes","volume":"107","author":"Betz","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1017\/S0033291722000319","article-title":"Acceptability of Cognitive Remediation for Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"53","author":"Vita","year":"2023","journal-title":"Psychol. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1176\/appi.ajp.20230396","article-title":"Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials","volume":"181","author":"Vita","year":"2024","journal-title":"Am. J. Psychiatry"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.schres.2019.10.047","article-title":"Cognitive Remediation for Schizophrenia: An Expert Working Group White Paper on Core Techniques","volume":"215","author":"Bowie","year":"2020","journal-title":"Schizophr. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2020.11.060","article-title":"Exploring the Role of Age as a Moderator of Cognitive Remediation for People with Schizophrenia","volume":"228","author":"Seccomandi","year":"2021","journal-title":"Schizophr. Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev-clinpsy-032511-143134","article-title":"Cognitive Interventions Targeting Brain Plasticity in the Prodromal and Early Phases of Schizophrenia","volume":"9","author":"Fisher","year":"2013","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2174\/138161212799316091","article-title":"Cognitive Remediation in the Early Course of Schizophrenia: A Critical Review","volume":"18","author":"Barlati","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/eip.13424","article-title":"Participant Perspectives on Cognitive Remediation and Social Recovery in Early Psychosis (CReSt-R): An Acceptability Study","volume":"18","author":"Frawley","year":"2024","journal-title":"Early Interv. Psychiatry"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.psychres.2019.02.007","article-title":"Integrative Cognitive Remediation for Early Psychosis: Results from a Randomized Controlled Trial","volume":"273","author":"Vidarsdottir","year":"2019","journal-title":"Psychiatry Res."},{"key":"ref_118","first-page":"57","article-title":"Cognitive remediation\u2014Where are we now and what should we do next?","volume":"24","author":"Wykes","year":"2018","journal-title":"Off. J. Ital. Soc. Psychopathol."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Nibbio, G., Barlati, S., Cacciani, P., Corsini, P., Mosca, A., Ceraso, A., Deste, G., and Vita, A. (2020). Evidence-Based Integrated Intervention in Patients with Schizophrenia: A Pilot Study of Feasibility and Effectiveness in a Real-World Rehabilitation Setting. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17103352"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Montemagni, C., Del Favero, E., Riccardi, C., Canta, L., Toye, M., Zanalda, E., and Rocca, P. (2021). Effects of Cognitive Remediation on Cognition, Metacognition, and Social Cognition in Patients with Schizophrenia. Front. Psychiatry, 12.","DOI":"10.3389\/fpsyt.2021.649737"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajp.2016.10.001","article-title":"A Review of Indian Research on Cognitive Remediation for Schizophrenia","volume":"25","author":"Hegde","year":"2017","journal-title":"Asian J. Psychiatry"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"551","DOI":"10.32598\/bcn.2021.3112.1","article-title":"A Short Course Computer-Assisted Cognitive Remediation in Patients with Schizophrenia Spectrum Disorders: A Randomized Clinical Trial","volume":"12","author":"Hatami","year":"2021","journal-title":"Basic Clin. Neurosci."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/00207640231181526","article-title":"Implementation of Cognitive Rehabilitation Interventions for Schizophrenia in Low-Income Countries: An Experience from Togo and Benin","volume":"70","author":"Vita","year":"2023","journal-title":"Int. J. Soc. Psychiatry"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Deste, G., Kakli, M., Barlati, S., Nibbio, G., Dossou, P., Degila, S.L., Ceraso, A., Lisoni, J., Calzavara-Pinton, I., and Villa, S. (2024). Application of Cognitive Remediation in the World: New Experiences from Two Schizophrenia Rehabilitation Centers in Togo and Benin. Soc. Psychiatry Psychiatr. Epidemiol.","DOI":"10.1007\/s00127-023-02603-z"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1037\/rep0000552","article-title":"Cognitive Remediation for Schizophrenia: Clinician Perspectives on Implementation Barriers and Facilitators","volume":"69","author":"Altman","year":"2024","journal-title":"Rehabil. Psychology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/07067437221129073","article-title":"Factors Impacting Access and Engagement of Cognitive Remediation Therapy for People with Schizophrenia: A Systematic Review","volume":"68","author":"Altman","year":"2023","journal-title":"Can. J. Psychiatry"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1177\/00048674231160987","article-title":"The Use of Implementation Science to Close the Research-to-Treatment Gap for Cognitive Impairment in Psychosis","volume":"57","author":"Zbukvic","year":"2023","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Saperstein, A.M., Bello, I., Nossel, I., Dixon, L.B., and Medalia, A. (2024). Implementation of Cognitive Health Services in Large Systems of Care: Highlights from Coordinated Specialty Care for First Episode Psychosis. Schizophr. Bull., sbae030.","DOI":"10.1093\/schbul\/sbae030"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Dark, F.L., Amado, I., Erlich, M.D., and Ikezawa, S. (2024). International Experience of Implementing Cognitive Remediation for People with Psychotic Disorders. Schizophr. Bull., sbae071.","DOI":"10.1093\/schbul\/sbae071"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1192\/j.eurpsy.2020.115","article-title":"Identification and Management of Cardiometabolic Risk in Subjects with Schizophrenia Spectrum Disorders: A Delphi Expert Consensus Study","volume":"64","author":"Galderisi","year":"2021","journal-title":"Eur. Psychiatry"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Schmitt, A., Maurus, I., Rossner, M.J., R\u00f6h, A., Lembeck, M., von Wilmsdorff, M., Takahashi, S., Rauchmann, B., Keeser, D., and Hasan, A. (2018). Effects of Aerobic Exercise on Metabolic Syndrome, Cardiorespiratory Fitness, and Symptoms in Schizophrenia Include Decreased Mortality. Front. Psychiatry, 9.","DOI":"10.3389\/fpsyt.2018.00690"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.neubiorev.2021.01.005","article-title":"In- and Outpatient Lifestyle Interventions on Diet and Exercise and Their Effect on Physical and Psychological Health: A Systematic Review and Meta-Analysis of Randomised Controlled Trials in Patients with Schizophrenia Spectrum Disorders and First Episode of Psychosis","volume":"125","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1017\/S0033291714003110","article-title":"A Systematic Review and Meta-Analysis of Exercise Interventions in Schizophrenia Patients","volume":"45","author":"Firth","year":"2015","journal-title":"Psychol. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.genhosppsych.2019.11.002","article-title":"Physical Exercise for Negative Symptoms of Schizophrenia: Systematic Review of Randomized Controlled Trials and Meta-Analysis","volume":"62","author":"Sabe","year":"2020","journal-title":"Gen. Hosp. Psychiatry"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/schbul\/sbv164","article-title":"Exercise Improves Clinical Symptoms, Quality of Life, Global Functioning, and Depression in Schizophrenia: A Systematic Review and Meta-Analysis","volume":"42","author":"Dauwan","year":"2016","journal-title":"Schizophr. Bull."},{"key":"ref_136","first-page":"546","article-title":"Aerobic Exercise Improves Cognitive Functioning in People with Schizophrenia: A Systematic Review and Meta-Analysis","volume":"43","author":"Firth","year":"2017","journal-title":"Schizophr. Bull."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"114656","DOI":"10.1016\/j.psychres.2022.114656","article-title":"Aerobic Exercise and Cognitive Functioning in Schizophrenia: An Updated Systematic Review and Meta-Analysis","volume":"314","author":"Shimada","year":"2022","journal-title":"Psychiatry Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.schres.2023.04.012","article-title":"The Effect of Exercise on Global, Social, Daily Living and Occupational Functioning in People Living with Schizophrenia: A Systematic Review and Meta-Analysis","volume":"256","author":"Korman","year":"2023","journal-title":"Schizophr. Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1017\/S0033291722001696","article-title":"Aerobic Exercise Enhances Cognitive Training Effects in First-Episode Schizophrenia: Randomized Clinical Trial Demonstrates Cognitive and Functional Gains","volume":"53","author":"Nuechterlein","year":"2022","journal-title":"Psychol. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41537-022-00297-x","article-title":"CCRT and Aerobic Exercise: A Randomised Controlled Study of Processing Speed, Cognitive Flexibility, and Serum BDNF Expression in Schizophrenia","volume":"8","author":"Dai","year":"2022","journal-title":"Schizophrenia"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Deste, G., Corbo, D., Nibbio, G., Italia, M., Dell\u2019Ovo, D., Calzavara-Pinton, I., Lisoni, J., Barlati, S., Gasparotti, R., and Vita, A. (2023). Impact of Physical Exercise Alone or in Combination with Cognitive Remediation on Cognitive Functions in People with Schizophrenia: A Qualitative Critical Review. Brain Sci., 13.","DOI":"10.3390\/brainsci13020320"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"113656","DOI":"10.1016\/j.psychres.2020.113656","article-title":"Effects of Transcranial Electrical Stimulation on Working Memory in Patients with Schizophrenia: A Systematic Review and Meta-Analysis","volume":"296","author":"Liu","year":"2021","journal-title":"Psychiatry Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.schres.2019.11.011","article-title":"Effect of Multi-Session Prefrontal Transcranial Direct Current Stimulation on Cognition in Schizophrenia: A Systematic Review and Meta-Analysis","volume":"216","author":"Narita","year":"2020","journal-title":"Schizophr. Res."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/0020764020972131","article-title":"Occupational Stress, Mental Health, and Self-Efficacy among Community Mental Health Workers: A Cross-Sectional Study during COVID-19 Pandemic","volume":"67","author":"Sun","year":"2021","journal-title":"Int. J. Soc. Psychiatry"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jpsychires.2022.09.011","article-title":"Effects of Bilateral, Bipolar-Nonbalanced, Frontal Transcranial Direct Current Stimulation (tDCS) on Negative Symptoms and Neurocognition in a Sample of Patients Living with Schizophrenia: Results of a Randomized Double-Blind Sham-Controlled Trial","volume":"155","author":"Lisoni","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Kubota, R., Ikezawa, S., Oi, H., Oba, M.S., Izumi, S., Tsuno, R., Adachi, L., Miwa, M., Toya, S., and Nishizato, Y. (2024). Valuable Interaction with Cognitive Remediation and Optimal Antipsychotics for Recovery in Schizophrenia (VICTORY-S): Study Protocol for an Interventional, Open-Label, Randomized Comparison of Combined Treatment with Cognitive Remediation and Lurasidone or Paliperidone. Front. Psychiatry, 14.","DOI":"10.3389\/fpsyt.2023.1331356"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4088\/JCP.15m09998","article-title":"A Multicenter, Rater-Blinded, Randomized Controlled Study of Auditory Processing-Focused Cognitive Remediation Combined with Open-Label Lurasidone in Patients with Schizophrenia and Schizoaffective Disorder","volume":"77","author":"Kantrowitz","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2215-0366(20)30307-2","article-title":"How Mental Health Care Should Change as a Consequence of the COVID-19 Pandemic","volume":"7","author":"Moreno","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Minelli, A., Silva, R.C., Barlati, S., Vezzoli, M., Carletto, S., Isabello, C., Bortolomasi, M., Nibbio, G., Lisoni, J., and Menesello, V. (2022). The Elephant in the Room: A Cross-Sectional Study on the Stressful Psychological Effects of the COVID-19 Pandemic in Mental Healthcare Workers. Brain Sci., 12.","DOI":"10.3390\/brainsci12030408"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/qjmed\/hcaa110","article-title":"Mental Health in the COVID-19 Pandemic","volume":"113","author":"Cullen","year":"2020","journal-title":"QJM Int. J. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jad.2020.08.001","article-title":"Impact of COVID-19 Pandemic on Mental Health in the General Population: A Systematic Review","volume":"277","author":"Xiong","year":"2020","journal-title":"J. Affect. Disord."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/YCO.0000000000000702","article-title":"Schizophrenia during the COVID-19 Pandemic","volume":"34","author":"Barlati","year":"2021","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/schbul\/sbaa051","article-title":"The COVID-19 Global Pandemic: Implications for People with Schizophrenia and Related Disorders","volume":"46","author":"Kozloff","year":"2020","journal-title":"Schizophr. Bull."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Mohan, M., Perry, B.I., Saravanan, P., and Singh, S.P. (2021). COVID-19 in People with Schizophrenia: Potential Mechanisms Linking Schizophrenia to Poor Prognosis. Front. Psychiatry, 12.","DOI":"10.3389\/fpsyt.2021.666067"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"114878","DOI":"10.1016\/j.psychres.2022.114878","article-title":"Long-Acting Injectable Antipsychotics during the COVID-19 Pandemic in Schizophrenia: An Observational Study in a Real-World Clinical Setting","volume":"317","author":"Barlati","year":"2022","journal-title":"Psychiatry Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.4088\/JCP.20com13412","article-title":"Perspectives on the COVID-19 Pandemic and Individuals with Serious Mental Illness","volume":"81","author":"Shinn","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/schbul\/sbaa158","article-title":"Disparities in Intensive Care Unit Admission and Mortality Among Patients with Schizophrenia and COVID-19: A National Cohort Study","volume":"47","author":"Fond","year":"2021","journal-title":"Schizophr. Bull."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.jaip.2020.03.008","article-title":"Telemedicine in the Era of COVID-19","volume":"8","author":"Portnoy","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"e000530","DOI":"10.1136\/fmch-2020-000530","article-title":"Telemedicine, the Current COVID-19 Pandemic and the Future: A Narrative Review and Perspectives Moving Forward in the USA","volume":"8","author":"Kichloo","year":"2020","journal-title":"Fam. Med. Community Health"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"583","DOI":"10.31083\/j.rcm.2020.04.188","article-title":"Utility of Telemedicine in the COVID-19 Era","volume":"21","author":"Colbert","year":"2020","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"100238","DOI":"10.1016\/j.scog.2022.100238","article-title":"Can Cognitive Remediation Therapy Be Delivered Remotely? A Review Examining Feasibility and Acceptability of Remote Interventions","volume":"28","author":"Jagtap","year":"2022","journal-title":"Schizophr. Res. Cogn."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.scog.2017.07.003","article-title":"Feasibility and Preliminary Efficacy of Remotely Delivering Cognitive Training to People with Schizophrenia Using Tablets","volume":"10","author":"Biagianti","year":"2017","journal-title":"Schizophr. Res. Cogn."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/schbul\/sbt232","article-title":"Neuroplasticity-Based Auditory Training via Laptop Computer Improves Cognition in Young Individuals with Recent Onset Schizophrenia","volume":"41","author":"Fisher","year":"2015","journal-title":"Schizophr. Bull."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.schres.2015.09.004","article-title":"Computerised Working-Memory Focused Cognitive Remediation Therapy for Psychosis--A Preliminary Study","volume":"169","author":"Hargreaves","year":"2015","journal-title":"Schizophr. Res."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.schres.2012.11.033","article-title":"Cognitive Training at Home in Schizophrenia Is Feasible","volume":"143","author":"Ventura","year":"2013","journal-title":"Schizophr. Res."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/NMD.0000000000001055","article-title":"Facilitating the Delivery of Cognitive Remediation in First-Episode Psychosis: Pilot Study of a Home-Delivered Web-Based Intervention","volume":"207","author":"Moura","year":"2019","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.2196\/mental.6982","article-title":"Web-Based Cognitive Remediation Improves Supported Employment Outcomes in Severe Mental Illness: Randomized Controlled Trial","volume":"4","author":"Harris","year":"2017","journal-title":"JMIR Ment. Health"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1017\/S0033291717001982","article-title":"Effectiveness of a Low Support, Remotely Accessible, Cognitive Remediation Training Programme for Chronic Psychosis: Cognitive, Functional and Cortical Outcomes from a Single Blind Randomised Controlled Trial","volume":"48","author":"Donohoe","year":"2018","journal-title":"Psychol. Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/schbul\/sbac209","article-title":"Efficacy of Remotely Delivered Evidence-Based Psychosocial Treatments for Schizophrenia-Spectrum Disorders: A Series of Systematic Reviews and Meta-Analyses","volume":"49","author":"Best","year":"2023","journal-title":"Schizophr. Bull."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"e48634","DOI":"10.2196\/48634","article-title":"The Effects of Remote Cognitive Training Combined With a Mobile App Intervention on Psychosis: Double-Blind Randomized Controlled Trial","volume":"25","author":"Fisher","year":"2023","journal-title":"J. Med. Internet Res."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Krzystanek, M., Krysta, K., Borkowski, M., Ska\u0142acka, K., Przyby\u0142o, J., Pa\u0142asz, A., Mucic, D., Martyniak, E., and Waszkiewicz, N. (2020). The Effect of Smartphone-Based Cognitive Training on the Functional\/Cognitive Markers of Schizophrenia: A One-Year Randomized Study. J. Clin. Med., 9.","DOI":"10.3390\/jcm9113681"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5765\/jkacap.190037","article-title":"The Use of Virtual Reality in Psychiatry: A Review","volume":"31","author":"Kim","year":"2020","journal-title":"J. Korean Acad. Child Adolesc. Psychiatry"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11920-017-0836-0","article-title":"Review of Virtual Reality Treatment in Psychiatry: Evidence Versus Current Diffusion and Use","volume":"19","author":"Mishkind","year":"2017","journal-title":"Curr. Psychiatry Rep."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Park, M.J., Kim, D.J., Lee, U., Na, E.J., and Jeon, H.J. (2019). A Literature Overview of Virtual Reality (VR) in Treatment of Psychiatric Disorders: Recent Advances and Limitations. Front. Psychiatry, 10.","DOI":"10.3389\/fpsyt.2019.00505"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"e28502","DOI":"10.2196\/28502","article-title":"Feasibility and Efficacy of Virtual Reality Interventions to Improve Psychosocial Functioning in Psychosis: Systematic Review","volume":"9","author":"Schroeder","year":"2022","journal-title":"JMIR Ment. Health"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/17522439.2023.2197030","article-title":"Virtual Reality for Clinical Evaluation and Treatment in Schizophrenia: A Systematic Review","volume":"16","author":"Gillouin","year":"2024","journal-title":"Psychosis"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Perra, A., Riccardo, C.L., De Lorenzo, V., De Marco, E., Di Natale, L., Kurotschka, P.K., Preti, A., and Carta, M.G. (2023). Fully Immersive Virtual Reality-Based Cognitive Remediation for Adults with Psychosocial Disabilities: A Systematic Scoping Review of Methods Intervention Gaps and Meta-Analysis of Published Effectiveness Studies. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20021527"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13063-024-07910-7","article-title":"Effect of Immersive Virtual Reality-Based Cognitive Remediation in Patients with Mood or Psychosis Spectrum Disorders: Study Protocol for a Randomized, Controlled, Double-Blinded Trial","volume":"25","author":"Jespersen","year":"2024","journal-title":"Trials"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"e54251","DOI":"10.2196\/54251","article-title":"Navigating Social Cognitive Impairments in Schizophrenia Spectrum Disorders: Protocol for a Pilot Pre-Post Quasi-Experimental Study for Remote Avatar-Assisted Cognitive Remediation Therapy","volume":"13","author":"Thibaudeau","year":"2024","journal-title":"JMIR Res. Protoc."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"e43904","DOI":"10.2196\/43904","article-title":"Co-Design of a Virtual Reality Cognitive Remediation Program for Depression (bWell-D) With Patient End Users and Clinicians: Qualitative Interview Study among Patients and Clinicians","volume":"11","author":"Hernandez","year":"2023","journal-title":"JMIR Serious Games"},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Perra, A., Galetti, A., Zaccheddu, R., Locci, A., Piludu, F., Preti, A., Primavera, D., Di Natale, L., Nardi, A.E., and Kurotshka, P.K. (2023). A Recovery-Oriented Program for People with Bipolar Disorder through Virtual Reality-Based Cognitive Remediation: Results of a Feasibility Randomized Clinical Trial. J. Clin. Med., 12.","DOI":"10.3390\/jcm12062142"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1017\/S0033291720003670","article-title":"Efficacy of Non-Invasive Brain Stimulation on Cognitive Functioning in Brain Disorders: A Meta-Analysis","volume":"50","author":"Begemann","year":"2020","journal-title":"Psychol. Med."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11065-020-09454-4","article-title":"Non-Invasive Brain Stimulation Does Not Improve Working Memory in Schizophrenia: A Meta-Analysis of Randomised Controlled Trials","volume":"31","author":"Sloan","year":"2021","journal-title":"Neuropsychol. Rev."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Jiang, Y., Guo, Z., Xing, G., He, L., Peng, H., Du, F., McClure, M.A., and Mu, Q. (2019). Effects of High-Frequency Transcranial Magnetic Stimulation for Cognitive Deficit in Schizophrenia: A Meta-Analysis. Front. Psychiatry, 10.","DOI":"10.3389\/fpsyt.2019.00135"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1037\/bul0000406","article-title":"The Efficacy of Combining Cognitive Training and Noninvasive Brain Stimulation: A Transdiagnostic Systematic Review and Meta-Analysis","volume":"150","author":"Poppe","year":"2024","journal-title":"Psychol. Bull."}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/14\/8\/791\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:30:46Z","timestamp":1760110246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/14\/8\/791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":185,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["brainsci14080791"],"URL":"https:\/\/doi.org\/10.3390\/brainsci14080791","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]}}}